Jody A. Charnow

Editor

Jody A. Charnow has been the editor of Renal & Urology News, a publication of Haymarket Media, since 2003. Previously, he had served as editor of Internal Medicine World Report and a managing editor for Medical Tribune. He holds a BA in biology from the State University of New York at Albany.

All articles by Jody A. Charnow

Biomarkers Help Distinguish Prostate Cancer from Prostatitis

Cardiovascular and Metabolic Disorders

Hyperuricemia Increases Risks for Cardiovascular, All-Cause Mortality

Jody A. Charnow

July 29, 2021

Each 1 mg/dL rise in uric acid level was significantly associated with a 21% and 10% increased risk for cardiovascular and all-cause mortality, respectively, a study found.

Androgen and Reproductive Disorders

COVID-19 Is Associated With Low Testosterone in Men

Jody A. Charnow

July 15, 2021

Study reveals that almost 90% of men have hypogonadism at the time of hospital admission for COVID-19.

Obesity

Obesity Linked to Lower Death Risk in mCRPC

Jody A. Charnow

July 13, 2021

Obesity in men with metastatic castration-resistant prostate cancer is associated with decreased risks for all-cause and cancer-specific mortality compared with overweight and normal-weight men.

Diabetes

Metformin Possibly Beneficial in Advanced Prostate Cancer

Jody A. Charnow

July 2, 2021

In a randomized controlled study, adding metformin to androgen deprivation therapy for low-tumor-volume metastatic hormone-sensitive prostate cancer significantly delayed development of castration-resistant disease.

Prehypertension in Pregnancy Predicts Metabolic Syndrome

Diabetes

Gestational Diabetes Followed by Type 2 Diabetes Ups CKD, ESKD Risk

Jody A. Charnow

June 15, 2021

In a study of Swedish women, gestational diabetes that progressed to type 2 diabetes was significantly associated with increased risks for chronic kidney disease and end-stage kidney disease.

Computed tomography scan demonstrating a large left renal mass that has invaded surrounding structures.

Diabetes

Post-Transplant New-Onset Diabetes Tied to Low Skeletal Muscle Attenuation

Jody A. Charnow

June 14, 2021

In a study, renal transplant recipients in the lowest quartile of skeletal muscle attenuation had 2-fold increased risk for new-onset diabetes after transplantation.

health worker talking to a man about his medication at home

Diabetes

Dapagliflozin Slows Progression of Focal Segmental Glomerulosclerosis

Jody A. Charnow

June 14, 2021

Dapagliflozin, an oral SGLT2 inhibitor, decreased the risk of progression of focal segmental glomerulosclerosis compared with placebo, a subgroup analysis of the DAPA-CKD trial showed.

Diabetes

Renoprotective Effect of SGLT2 Inhibitors Mediated Largely by Hematocrit

Jody A. Charnow

June 11, 2021

Increases in the proportion of red blood cells mediates the reduction in renal risks associated with SGLT2 inhibitor therapy in patients with type 2 diabetes and cardiovascular disease, a study found.

Obesity

Visceral Fat Area Better at Predicting CV Outcomes in the HD Population

Jody A. Charnow

May 20, 2021

Visceral fat area was significantly associated with the risk for cardiovascular events and death and all-cause mortality, whereas coronary artery calcification score was not, a study found.

Cardiovascular and Metabolic Disorders

Renal Denervation Demonstrates Positive Effects in Hypertension Study

Jody A. Charnow

May 7, 2021

In a clinical trial, renal denervation was associated with decreased plasma renin activity and aldosterone levels compared with a sham procedure.

Next post in Cardiovascular and Metabolic Disorders